NCT01406002View on ClinicalTrials.gov

To Evaluate if Multiple Doses of Rifampicin Change the Blood Concentration of YM150 (Darexaban)

PHASE1CompletedINTERVENTIONAL
Enrollment

26

Participants

Timeline

Start Date

January 31, 2010

Primary Completion Date

March 31, 2010

Study Completion Date

March 31, 2010

Conditions
Pharmacokinetics of Darexaban and MetabolitesHealthy Subjects
Interventions
DRUG

darexaban

oral

DRUG

Rifampicin

oral

Trial Locations (1)

75015

SGS Aster, Paris

Sponsors
All Listed Sponsors
lead

Astellas Pharma Inc

INDUSTRY